DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Endroit courant :
> This Story

Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment




Business Affairs Homepage

Empowering patients is more transformational than you thought (or feared) Understanding a shifting paradigm in the care continuum

J. Michael Losh Cardinal Health appoints member to board of directors

Dr. Michael Rosol Navidea Biopharmaceuticals appoints chief medical officer

MDW aims to combat radiologist shortage with blockchain Connecting radiologists seeking volume to the facilities that need reading support

United Imaging Healthcare makes US debut at RSNA Bringing MR, CT, X-ray and PET/CT manufacturing to Houston

Dr. Hermann Requardt United Imaging Healthcare appoints senior scientific advisor

Dr. Jaewon Ryu Geisinger appoints interim president and CEO

Dr. Kent Thielen Mayo Clinic appoints CEO of its Florida operations; board of trustees names two new members

Medical charities do measurable good in the world A look at some organizations bringing goods and services where they are needed most

Mike Lobinsky EOS Imaging appoints new President North America

Veritas-backed Verscend closes $4.9 billion deal for Cotiviti

par Thomas Dworetzky , Contributing Reporter
Verscend, a data-driven healthcare solutions provider and portfolio company of Veritas Capital, has closed its $4.9 billion cash deal for healthcare industry payment accuracy and analytics provider, Cotiviti.

“We believe Cotiviti is a perfect fit with both our investment strategy and with Verscend, and we look forward to taking the platform to the next level through this exciting combination,” said Ramzi Musallam, CEO and Managing Partner of Veritas Capital, in a statement when the deal was announced.

Story Continues Below Advertisement

RamSoft PowerServer™ RIS/PACS - Enabling Efficient Diagnostic Imaging

RamSoft's PowerServer™ RIS/PACS is an intuitive, single database application that enables healthcare practices to operate diagnostic imaging more efficiently than ever before.Why is this important? Click to find out.

Veritas aims to invest in such “transformational impact,” noted Musallam on the closing of the deal. “We see the combination of Cotiviti and Verscend as bringing much needed precision and insight to the healthcare system,” he stated. “We expect that the two companies’ complementary data sets, analytical capabilities, and industry expertise will accelerate forward momentum for the new Cotiviti through smarter, faster solutions that address rising costs, eliminate waste, and speed quality improvement for the healthcare industry overall.”

The deal delivered $44.75 in cash for each Cotiviti common stock, plus the assumption of all outstanding debt by Verscend.

The two will run as a combined private company under the name of Cotiviti and Dr. Emad Rizk, Verscend president and CEO, will retain his titles in the new firm.

“We are thrilled to partner with Cotiviti, which has become an important player in the growing and increasingly important and complex healthcare payment accuracy space,” said Rizk when the deal was announced in June.

The combined company is aiming at one of the greatest challenges in healthcare financial performance – getting the payments right and catching fraud, waste and abuse. Having both financial and clinical data with which to work, Cotiviti “will have unique insight” into healthcare finances in a rapidly changing landscape.

“Both companies are customer-driven innovators that share a similar mission: to help our clients improve healthcare affordability, reduce waste, and identify the best path to better outcomes,” said Rizk. “With our new capabilities across payment, quality, risk, and the combination of clinical and financial data, Cotitivi will be unmatched in its ability to create differentiated value for its clients.”

Veritas Capital was in the news lately with its GE Healthcare’s Value-Based Care Division acquisition, which closed in July.

When it closed the billion-dollar deal, Musallam called it “an exciting chapter.”

The deal followed the “corporate carve-out” pattern of prior Veritas investments in healthcare tech – including those in Truven Health Analytics and Verscend.

IBM acquired Truven Health Analytics, a provider of cloud-based health care data, analytics and insights, for $2.6 billion in 2016 from Veritas.

The Truven purchase showed “we’re serious, and spending serious money to move fast in a whole new industry for IBM,” John E. Kelly, IBM senior vice president, said at the time.

Veritas Capital had bought Truven from Thomson Reuters for $1.25 billion in 2012, according to Reuters.

Business Affairs Homepage

You Must Be Logged In To Post A Comment

Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2018, Inc.